Cite
HARVARD Citation
Lastiri, E. et al. (n.d.). P626 Anti-TNF monotherapy is associated with an adverse clinical outcome in female Inflammatory Bowel Disease patients who stop Anti-TNF treatment during the third trimester of pregnancy. Journal of Crohn's and colitis. pp. i549-i550. [Online].